-
Post date
December 29, 2023
-
Posted by
GaalenEngen
-
Posted in
Antidepressant Efficacy, Canadian healthcare, Core Story, Depression in Canada, Health Science, Investment Opportunities in Healthcare, mdma for ptsd, Mental Health Awareness, Mental Health Care, Mental Health Crisis, Mental Health Disorders, Mental Health Policy, Mental Health Statistics, Mushrooms, Optimi Health Corp., Optimi Health Developments, Pharmaceutical Innovation, psychedelic assisted therapy, Psychedelic Drug Candidates, Psychedelics, Today's Idea, Treatment-resistant Depression, Wellness
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
March 18, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks, Canadian psychedelics companies, Canadian psychedelics market, clinical trials psychedelics, Dealer's License, Health Canada approval, licensed dealer, medical psychedelics, mushroom, mushroom formulation, mushroom laws, mushroom legalization, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, natural psychedelics, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin mushrooms, Psychedelics, psychedelics stocks 2022
-
Post date
March 18, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks, Canadian psychedelics companies, Canadian psychedelics market, clinical trials psychedelics, Dealer's License, Health Canada approval, licensed dealer, medical psychedelics, mushroom, mushroom formulation, mushroom laws, mushroom legalization, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, natural psychedelics, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin mushrooms, Psychedelics, psychedelics stocks 2022
